BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’
1st July 2026 Uncategorised 0As BridgeBio ramps up for the launch of three new medicines and continues to channel resources into its soon-to-be-blockbuster in ATTR-CM, Attruby, Sixth Street and HealthCare Royalty have agreed to invest up to $1 billion in the California biotech. More:
read more